Invesco Ltd. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,567,315
-80.4%
540,676
-53.1%
0.01%
-78.6%
Q2 2023$104,983,277
+52.9%
1,152,396
+10.7%
0.03%
+47.4%
Q1 2023$68,663,108
+165.2%
1,040,981
+107.9%
0.02%
+137.5%
Q4 2022$25,895,695
-37.1%
500,787
-17.0%
0.01%
-38.5%
Q3 2022$41,202,000
+424.8%
603,253
+247.4%
0.01%
+550.0%
Q2 2022$7,851,000
+16.0%
173,628
+30.4%
0.00%0.0%
Q1 2022$6,768,000
+194.9%
133,183
+174.3%
0.00%
+100.0%
Q4 2021$2,295,000
+27.2%
48,549
-11.3%
0.00%
Q3 2021$1,804,000
-95.2%
54,738
-90.8%
0.00%
-100.0%
Q2 2021$37,725,000
+62.8%
596,916
+10.5%
0.01%
+50.0%
Q1 2021$23,176,000
-27.8%
540,107
-3.7%
0.01%
-33.3%
Q4 2020$32,094,000
+46.4%
561,092
-22.8%
0.01%
+28.6%
Q3 2020$21,927,000
+17.4%
726,777
+27.0%
0.01%0.0%
Q2 2020$18,685,000
+95.0%
572,113
+60.0%
0.01%
+75.0%
Q1 2020$9,582,000
+827.6%
357,676
+777.1%
0.00%
Q2 2019$1,033,00040,7790.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders